Lavipharm SA
F:BXA0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lavipharm SA
F:BXA0
|
GR |
|
S
|
Secern AI Co Ltd
KOSDAQ:340810
|
KR |
|
E
|
EFU Life Assurance Ltd
KAR:EFUL
|
PK |
|
A
|
Anpec Electronics Corp
TPEX:6138
|
TW |
|
T
|
Taitien Electronics Co Ltd
TPEX:8289
|
TW |
|
H
|
Hana Twenty-Nine Special Purpose Acquisition Co
KOSDAQ:454640
|
KR |
|
P
|
Pakistan Reinsurance Company Ltd
KAR:PAKRI
|
PK |
|
G
|
Grade Upon Technology Corp
TPEX:6739
|
TW |
|
J
|
Jubilee Spinning & Weaving Mills Ltd
KAR:JUBS
|
PK |
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
KR |
|
I
|
International Knitwear Ltd
KAR:INKL
|
PK |
|
Solikamskiy Magniyevyi Zavod OAO
MOEX:MGNZ
|
RU |
|
S
|
Stabilus SE
XMUN:STM
|
DE |
|
P
|
Panram International Corp
TPEX:8088
|
TW |
|
F
|
Forrester Research Inc
F:FFR
|
US |
|
P
|
Prima Multi Usaha Indonesia Tbk PT
IDX:PMUI
|
ID |
Bankruptcy Probability
Lavipharm SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lavipharm SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GR |
L
|
Lavipharm SA
ATHEX:LAVI
|
263.7m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
609.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
344.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
334.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
320.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
156.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lavipharm SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lavipharm SA has total debt of 26.8m EUR. This includes both short-term (6m EUR) and long-term (20.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.